190 related articles for article (PubMed ID: 31237179)
1. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia.
Muguruza C; Morentin B; Meana JJ; Alexander SP; Callado LF
J Psychopharmacol; 2019 Sep; 33(9):1132-1140. PubMed ID: 31237179
[TBL] [Abstract][Full Text] [Related]
2. Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.
Blanco E; Pavón FJ; Palomino A; Luque-Rojas MJ; Serrano A; Rivera P; Bilbao A; Alen F; Vida M; Suárez J; Rodríguez de Fonseca F
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539508
[TBL] [Abstract][Full Text] [Related]
3. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
5. 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1.
Farah SI; Hilston S; Tran N; Zvonok N; Makriyannis A
Biochem Biophys Res Commun; 2022 Feb; 591():31-36. PubMed ID: 34995983
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects.
Erdozain AM; Rubio M; Valdizan EM; Pazos A; Meana JJ; Fernández-Ruiz J; Alexander SP; Callado LF
Addict Biol; 2015 Jul; 20(4):773-83. PubMed ID: 25041461
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex.
Sticht MA; Limebeer CL; Rafla BR; Abdullah RA; Poklis JL; Ho W; Niphakis MJ; Cravatt BF; Sharkey KA; Lichtman AH; Parker LA
Neuropharmacology; 2016 Mar; 102():92-102. PubMed ID: 26541329
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase.
Tosun NC; Gunduz O; Ulugol A
J Neural Transm (Vienna); 2015 Mar; 122(3):363-7. PubMed ID: 24915981
[TBL] [Abstract][Full Text] [Related]
11. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
13. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression.
Fitzgibbon M; Kerr DM; Henry RJ; Finn DP; Roche M
Brain Behav Immun; 2019 Nov; 82():372-381. PubMed ID: 31505257
[TBL] [Abstract][Full Text] [Related]
15. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
17. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex.
Long LE; Lind J; Webster M; Weickert CS
BMC Neurosci; 2012 Jul; 13():87. PubMed ID: 22827915
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias.
Rodríguez-Cueto C; Benito C; Romero J; Hernández-Gálvez M; Gómez-Ruiz M; Fernández-Ruiz J
Pathobiology; 2014; 81(3):149-59. PubMed ID: 24642775
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
[TBL] [Abstract][Full Text] [Related]
20. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
